MeSH D000752 - pernicious anemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Allergan | Hydroxocobalamin | Hydroxocobalamin | 1982-01-01 | |||
| APP Pharmaceuticals | Hydroxocobalamin | Hydroxocobalamin | 1982-01-01 | |||
| Bel-Mar Laboratories | Hydroxocobalamin | Hydroxomin | 1982-01-01 | |||
| BTG | Hydroxocobalamin | Cyanokit | 2006-12-15 | |||
| Merck & Co | Hydroxocobalamin | Alpharedisol | 1982-01-01 | |||
| SERB | Hydroxocobalamin | Cyanokit | 2007-11-23 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
100%1/1
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use